Search research articles
Contact Us
Filters
Showing results (51-60 of 140) with videos related to
Page
of 14
Sort By:
Pharmaceutics
|
July 2, 2021
A Quantitative Pharmacology Model of Exosome-Mediated Drug Efflux and Perturbation-Induced Synergy
Jin Wang, Bertrand Z Yeung, M Guillaume Wientjes, et al.
Journal of Clinical Pharmacology
|
January 10, 2023
In Silico Re-Optimization of Atezolizumab Dosing Using Population Pharmacokinetic Simulation and Exposure-Response Simulation
Cody J Peer, Keith T Schmidt, Oluwatobi Arisa, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
January 14, 2020
Measurement of NLG207 (formerly CRLX101) nanoparticle-bound and released camptothecin in human plasma
Keith T Schmidt, Cody J Peer, Alwin D R Huitema, et al.
Comparative Medicine
|
October 13, 2020
Flow Rate and Apparent Volume of Cerebrospinal Fluid in Rhesus Macaques (<i>Macaca mulatta</i>) Based on the Pharmacokinetics of Intrathecally Administered Inulin
Cynthia M Lester McCully, Louis T Rodgers, Rafael Cruz Garica, et al.
Journal of Neuro-Oncology
|
March 15, 2017
Plasma and cerebrospinal fluid pharmacokinetics of select chemotherapeutic agents following intranasal delivery in a non-human primate model
James C League-Pascual, Cynthia M Lester-McCully, Shaefali Shandilya, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 16, 2008
Dehydroalanine analog of glutathione: an electrophilic busulfan metabolite that binds to human glutathione S-transferase A1-1
Islam R Younis, Meenal Elliott, Cody J Peer, et al.
Journal of Clinical Pharmacology
|
April 9, 2014
Effectiveness of clopidogrel dose escalation to normalize active metabolite exposure and antiplatelet effects in CYP2C19 poor metabolizers
Richard B Horenstein, Rajnikanth Madabushi, Issam Zineh, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
February 4, 2014
A sensitive and robust HPLC assay with fluorescence detection for the quantification of pomalidomide in human plasma for pharmacokinetic analyses
Shandiz Shahbazi, Cody J Peer, Mark N Polizzotto, et al.
Molecular Cancer Therapeutics
|
May 12, 2018
Novel Fluoroindenoisoquinoline Non-Camptothecin Topoisomerase I Inhibitors
Laetitia Marzi, Keli Agama, Junko Murai, et al.
The Oncologist
|
May 11, 2021
First-in-Human Phase I Study of Envafolimab, a Novel Subcutaneous Single-Domain Anti-PD-L1 Antibody, in Patients with Advanced Solid Tumors
Kyriakos P Papadopoulos, Wael Harb, Cody J Peer, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 140) with videos related to
Sort By:
Page
of 14
Pharmaceutics
|
July 2, 2021
A Quantitative Pharmacology Model of Exosome-Mediated Drug Efflux and Perturbation-Induced Synergy
Jin Wang, Bertrand Z Yeung, M Guillaume Wientjes, et al.
Journal of Clinical Pharmacology
|
January 10, 2023
In Silico Re-Optimization of Atezolizumab Dosing Using Population Pharmacokinetic Simulation and Exposure-Response Simulation
Cody J Peer, Keith T Schmidt, Oluwatobi Arisa, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
January 14, 2020
Measurement of NLG207 (formerly CRLX101) nanoparticle-bound and released camptothecin in human plasma
Keith T Schmidt, Cody J Peer, Alwin D R Huitema, et al.
Comparative Medicine
|
October 13, 2020
Flow Rate and Apparent Volume of Cerebrospinal Fluid in Rhesus Macaques (<i>Macaca mulatta</i>) Based on the Pharmacokinetics of Intrathecally Administered Inulin
Cynthia M Lester McCully, Louis T Rodgers, Rafael Cruz Garica, et al.
Journal of Neuro-Oncology
|
March 15, 2017
Plasma and cerebrospinal fluid pharmacokinetics of select chemotherapeutic agents following intranasal delivery in a non-human primate model
James C League-Pascual, Cynthia M Lester-McCully, Shaefali Shandilya, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 16, 2008
Dehydroalanine analog of glutathione: an electrophilic busulfan metabolite that binds to human glutathione S-transferase A1-1
Islam R Younis, Meenal Elliott, Cody J Peer, et al.
Journal of Clinical Pharmacology
|
April 9, 2014
Effectiveness of clopidogrel dose escalation to normalize active metabolite exposure and antiplatelet effects in CYP2C19 poor metabolizers
Richard B Horenstein, Rajnikanth Madabushi, Issam Zineh, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
February 4, 2014
A sensitive and robust HPLC assay with fluorescence detection for the quantification of pomalidomide in human plasma for pharmacokinetic analyses
Shandiz Shahbazi, Cody J Peer, Mark N Polizzotto, et al.
Molecular Cancer Therapeutics
|
May 12, 2018
Novel Fluoroindenoisoquinoline Non-Camptothecin Topoisomerase I Inhibitors
Laetitia Marzi, Keli Agama, Junko Murai, et al.
The Oncologist
|
May 11, 2021
First-in-Human Phase I Study of Envafolimab, a Novel Subcutaneous Single-Domain Anti-PD-L1 Antibody, in Patients with Advanced Solid Tumors
Kyriakos P Papadopoulos, Wael Harb, Cody J Peer, et al.
Page
of 14